Double chin fat dissolving injections Old Longueuil
Do you feel that your double chin doesn’t reflect your true facial appearance, even with a healthy lifestyle? You’re not alone. Many people experience submental fullness, which can be influenced by genetics, aging, or weight fluctuations. If you're looking for a non-surgical option to help refine the jawline and enhance facial contours, injectable treatments designed to reduce fat under the chin may be an option to consider.
The products used in our clinics are approved by the FDA and Health Canada and are designed to target and break down fat cells beneath the chin. Their active ingredient, deoxycholic acid, is a synthetic form of a molecule naturally found in the body that helps break down and absorb dietary fat. Once the fat cell membranes are disrupted, the body gradually eliminates them over time, which can contribute to a more defined appearance under the chin. Since the treated fat cells are destroyed, they do not regenerate.
Every patient is unique, and the best double chin treatment depends on your individual needs. A consultation with our specialists will help determine the right treatment plan for you. Want to learn more? Read our article on non-surgical double chin reduction while you wait for your consultation.
What to expect during your session
Personalized Assessment
Take Pictures
Apply a Numbing Gel
Begin Injections
Minimal Downtime
Treatment & Technology
At Dermapure Old Longueuil, deoxycholic acid injections are offered as a non-surgical injectable treatment to help reduce fullness under the chin. This approach works gradually by targeting this specific area, allowing the body to process the treated fat over time. Many patients notice a progressive improvement in chin and jawline definition.
Deoxycholic acid injections in Longueuil are available at our Old Longueuil clinic. Explore the full range of treatments offered in Longueuil and book an appointment to receive a personalized care plan.
Contraindications
Women who are pregnant or breastfeeding should not receive this treatment.